Ovalicin-d4;Graphinone-d4;(3S)-4?-Hydroxy-4-[(2S)-2-methyl-3?-(3-methyl-2-butenyl)oxirane-2?-yl]-5?-methoxy-1-oxaspiro[2.5]octane-6-one-d4;7-hydroxy-8-methoxy-7-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-4-oxaspiro[2.5]octan-2-one-d4
Ovalicin-d4 is a fully characterized chemical compound used as a reference standard of API Fumagillin. The standard offered is compliant with regulatory guidelines. Ovalicin-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 19683-98-8 (non-labelled)
